Genetic Engineering & Biotechnology specifies best practices for improving ADME/Tox efforts:
"Early-Drug Screening Is Due For Review - Before a new prescription medicine gains marketing approval, it typically goes through a development process that lasts at least a decade. Moreover, according to the Tufts Center for the Study of Drug Development, the costs can exceed $2.5 billion."
Read the complete article at: Genengnews.com